Overview of Sustiva – A Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Medication
Short general description of the drug Sustiva Sustiva is a highly effective medication that belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It is commonly prescribed for the treatment of HIV-1 infection, the most common type of HIV virus found in adults. As an NNRTI, Sustiva works by specifically targeting and inhibiting the reverse transcriptase enzyme, which is crucial for the replication and spread of the HIV virus. By blocking this enzyme, Sustiva effectively prevents the virus from multiplying and spreading throughout the body. Due to its reliable efficacy, Sustiva is often used in combination with other antiretroviral drugs as part of a comprehensive treatment regimen known as Highly Active Antiretroviral Therapy (HAART). This combination therapy approach helps to suppress the HIV virus, improve immune function, and reduce the risk of developing acquired immunodeficiency syndrome (AIDS). Sustiva is available in tablet form for oral administration and…